Search Results

Paclitaxel-Coated Balloon Angioplasty Studied to Treat Dysfunctional Arteriovenous Fistulas

March 12, 2015—One-year results of a single-center prospective randomized controlled trial comparing a paclitaxel-coated balloon (PCB) versus high-pressure plain balloon (HPB) angioplasty for the treatment of failing arteriovenous fistulas (AVFs) were reported by Panagiotis M. Kitrou, MD, et al in the Journal of Vascular and Interventional Radiology (JVIR; 2015;26:348–354).

Paclitaxel Versus Plain Balloon Angioplasty Compared in Treatment of Symptomatic Central Venous Stenosis in Dialysis Access

June 14, 2017—Results from a randomized controlled trial comparing the clinically assessed intervention-free period (IFP) of paclitaxel-coated balloon (PCB) angioplasty versus conventional balloon angioplasty (CBA) for the treatment of symptomatic central venous stenosis in dialysis access were published by Panagiotis M. Kitrou, MD, et al in Journal of Vascular and Interventional Radiology (JVIR; 2017;28:811–817).

BD’s WavelinQ EndoAVF Is Evaluated in Postmarket Studies

April 29, 2021—BD (Becton, Dickinson and Company) announced that enrollment has begun and the first patients have been treated in the CONNECT-AV postmarket surveillance study.

New Paclitaxel Meta-Analysis Questions Safety in CLI Population; Concerns Voiced as to Methods

January 15, 2020—In the wake of a year spent scrutinizing the finding of a mortality signal related to paclitaxel-coated balloons and stents in the superficial femoral artery (SFA), a new publication again calls the safety of paclitaxel into question, only this time in the critical limb ischemia (CLI) population.